• Testimonials
His understanding of polymorphic behavior and crystal form control resolved months of instability issues.
Post
A European biotech developing a new cocrystal-based drug candidate required guidance for intellectual property protection.
Read MorePost
A biotech startup developing a promising oncology API approached PharmaFormFinders after facing inconsistencies in dissolution performance.
Read More